Background: The evaluation of residual tumor size post-neoadjuvant chemotherapy (NAC) could have an impact on surgical planning. Accurate measurement may avoid overly radical surgery or reduce the need for repeat surgery. The purpose of this study is to evaluate the size of residual tumor after NAC using mammography and ultrasound or MRI and thereby establish which imaging method shows most agreement with histological result. Methods: Data from 125 patients, from 40 to 86 years old, with primary breast cancer and indication for neoadjuvant chemotherapy were analyzed in a retrospective study. All patients underwent conventional imaging (mammography and ultrasound) or MRI in addition to conventional imaging, after NAC and before surgery. Intra-class correlation (ICC) was calculated, and a Bland–Altman plot was used to determine the agreement between imaging residual tumor size (from US/mammography and MRI) and histological residual tumor size. The results were divided into the groups: invasive ductal carcinoma (IDC) + ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC) and “other tumors” (i.e., mucinous carcinoma). Results: Of 125 analyzed patients, 44 (34.65%) underwent MRI and 81 (65.35%) had conventional imaging only. Agreement between residual tumor size founded on MRI and histological size is stronger than the data from conventional imaging. Conclusions: MRI performance was generally superior to conventional imaging, and it may be considered the most appropriate test to evaluate the residual tumor size post-NAC before surgery.
Background: Neonatal birth-related intracranial subdural hemorrhages (SDHs) represent a form of bleeding inside the skull that occurs in newborns. This condition includes the extravasation of blood both in the encephalic parenchyma and in the extra-axial spaces. Recent studies have shown that SDH and particularly post-traumatic birth-related hemorrhages represent a frequent occurrence, but they are often asymptomatic. The gold standard for the diagnosis and follow-up of patients with SDH is multiparametric Magnetic Resonance Imaging. The aim of this study is to describe our experience by reporting several cases of SDH with different distribution and Central Nervous System involvement by the MRI of this pathology in infants up to 30 days of age. Methods: We analyzed the age and sex of the patients included in this study, the localization of SDH in different CNS areas, and their frequency using distribution plots and pie charts. Results: About the analysis of the SDH locations in the 32 patients, the most common location was the cerebellum (31/32, 96.9%), followed by parietal and occipital lobes (19/32, 59.4%; 18/32, 56.2%, respectively), falx cerebri (11/32, 34.4%), tentorium cerebelli (10/32, 31.2%), temporal lobes (6/32, 18.7%), and finally cervical and dorsal spine in the same patients (4/32, 12.5%). According to SDH locations, the patients were divided into supratentorial, infratentorial, both, and Spinal Canal. Conclusions: Our study confirmed the literature data regarding the neonatal birth-related SDH high frequency, but also allowed us to focus our attention on the rarest spinal SDH localizations with the same benign evolution.
Background: Breast density (BD) and background parenchymal enhancement (BPE) have long been considered related descriptors of breast tissue composition, yet growing evidence shows that they represent distinct and non-interchangeable physiological domains. Objective: This study aims to evaluate whether BD and BPE represent independent imaging biomarkers with distinct systemic associations, and to investigate their potential role in preventive medicine beyond breast cancer detection. Methods: Drawing on linear modeling, neural analyses, inverse prediction, and correlation studies conducted across five coordinated investigations, we evaluated the systemic associations of BD and BPE. We also performed model ablation analyses to confirm biomarker independence and assessed the impact of AI support on inter-reader agreement and workflow efficiency. Results: BD is strongly associated with bone mineral density, supporting its role as a structural marker linked to osteoporotic risk. Conversely, BPE correlates with systolic blood pressure (SBP), reflecting vascular tone and perfusion. Importantly, the systemic information carried by BD can be extracted not only from contrast enhanced mammography (CEM) but also from standard mammography. When CEM is available, BPE adds complementary insight into vascular physiology. Furthermore, AI support improved inter-reader agreement and workflow efficiency. Conclusions: These findings support a dual biomarker framework in which BD and BPE independently contribute to systemic risk stratification. This approach suggests potential for opportunistic osteoporosis risk assessment from routine screening examinations, though prospective validation is required before clinical implementation. This framework may shift breast imaging toward a broader, sustainable, and human-centered approach to preventive health.